Fitbit, Solera extend collaboration to lower type 2 diabetes risk
The companies seek to lower type 2 diabetes risk by using the Fitbit platform via the innovative model of Solera Health to encourage positive behavior changes, such as
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XThe companies seek to lower type 2 diabetes risk by using the Fitbit platform via the innovative model of Solera Health to encourage positive behavior changes, such as
Saranas has recently conducted a study on more than 17,000 large-bore transcatheter interventions from the National Inpatient Sample Database. The study revealed that one in five patients experienced
The approval has been given to VENTANA PD-L1 (SP142) Assay to identify triple-negative breast cancer (TNBC) patients eligible for treatment with the Roche cancer immunotherapy Tecentriq (atezolizumab) along
Silk Road Medical has applied to list on the Nasdaq under the ticker symbol SILK. JP Morgan and BofA Merrill Lynch are serving as lead managers on the
Sebacia is focused on creating advanced topical therapies for the treatment of dermatological conditions, with a primary focus on a procedure-based acne treatment. The company presented the results
The Accurian RF system has received 510(k) clearance from the US Food and Drug Administration (FDA). Medtronic said RF ablation is a minimally invasive procedure in which current
Microfluidics is capable of eliminating the discomfort and cost of needles or surgical procedures generally associated with tissue biopsies, as part of cancer diagnosis. The new microfluidics device
Neuroelectrics said of the seventeen patients that completed the study, treatment with Neuroelectrics’ Starstim device lead to a reduction in seizure frequency of about 40% from baseline in
Axonics is a medical technology company contributing for the development and commercialization of novel implantable SNM devices to treat the urinary and bowel dysfunction. SNM therapy is a
LivaNova said that the addition of Perceval into Japan’s health insurance system allows physicians and patients to have greater access to the biological heart valve. LivaNova Japan president